摘要
目的:探讨联合用药治疗肺结核的临床疗效。方法:随机抽取本院2005年1月-2011年10月收治的110例肺结核患者,随机分成联合用药观察组60例和对照组50例,进行疗效分析和总结。结果:观察组有效率为95.00%,不良反应发生率为36.67%;对照组有效率为70.00%,不良反应发生率达60.00%。两组有效率和不良反应发生率比较差异均有统计学意义(P<0.05),两组均无死亡病例。结论:选择合理的多种联合用药治疗肺结核临床疗效显著,且副作用少,抗耐药性强,值得临床不断尝试和探讨。
Objective： To study clinical efficacy of combined medication in treatment of pulmonary tuberculosis disease.Method： 110 cases of pulmonary tuberculosis were randomly divided into combination observation group （ n=60 ） and control group （ n=50 ） from January 2005 to October 2011, efficacy were analyzed.Result： The efficiency of observation group was 95.00%, the rate of adverse reactions was 36.67%. The efficiency of control group was 70.00%, the rate of adverse reactions was 60.O0%.The difference of two groups was significant （ P〈0.05 ）, no case died.Conclusion： Reasonable selection of multiple combination therapy in the treatment of pulmonary tuberculosis disease clinical curative effect is remarkable, and fewer side effects of antifungal resistance, strong, worthy of clinical trial and exploration.
出处
《中国医学创新》
CAS
2013年第17期26-27,共2页
Medical Innovation of China
关键词
肺结核
联合用药
疗效分析
Pulmonary tuberculosis
Drug combination
Curative effect analysis
